Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Huons Global Co., Ltd. (084110:KRX), powered by AI.
Huons Global Co., Ltd. is currently trading at ₩27,100. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Huons Global Co., Ltd. on Alpha Lenz.
Huons Global Co., Ltd.'s P/E ratio is 12.0.
“Huons Global Co., Ltd. trades at a P/E of 12.0 (undervalued) with modest ROE of 5.4%.”
Ask for details →Huons Global Co., Ltd. is a prominent player in the pharmaceutical and healthcare industry, engaging primarily in the production and distribution of comprehensive pharmaceutical solutions. The company focuses on developing high-quality medicines and healthcare products that address a range of medical needs, reinforcing its commitment to improving patient care and health outcomes globally. Huons Global is involved in the manufacturing of prescription drugs, over-the-counter (OTC) medications, and specialized medical devices, positioning itself as a versatile entity in the healthcare sector. With its headquarters in South Korea, Huons Global leverages significant expertise in research and development, emphasizing innovation and technology to create products that meet international standards. Its environment respects and adheres to stringent quality assurance protocols, ensuring top-tier product safety and efficacy. The company's influence extends into multiple sectors, including hospital pharmacies, private healthcare providers, and retail pharmaceutical outlets. As a key contributor to the healthcare market, Huons Global upholds a strategic role in addressing both transient and chronic conditions, bolstering its standing in the global context of healthcare production and distribution.
“Huons Global Co., Ltd. trades at a P/E of 12.0 (undervalued) with modest ROE of 5.4%.”
Ask for details →Huons Global Co., Ltd. (ticker: 084110) is a company listed on KRX in the Common Stock sector (Common Stock). Market cap is $346.2B.
The current price is ₩27,100 with a P/E ratio of 12.01x and P/B of 0.63x.
ROE is 5.41% and operating margin is 10.71%. Annual revenue is $847.5B.